A detailed history of Cannell & Co. transactions in Baxter International Inc stock. As of the latest transaction made, Cannell & Co. holds 371,873 shares of BAX stock, worth $12.9 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
371,873
Previous 393,293 5.45%
Holding current value
$12.9 Million
Previous $14.8 Million 3.14%
% of portfolio
0.48%
Previous 0.52%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$31.71 - $38.95 $679,228 - $834,309
-21,420 Reduced 5.45%
371,873 $14.4 Million
Q3 2023

Nov 14, 2023

BUY
$37.32 - $49.29 $579,131 - $764,882
15,518 Added 4.11%
393,293 $14.8 Million
Q2 2023

Aug 09, 2023

SELL
$39.98 - $47.68 $581,709 - $693,744
-14,550 Reduced 3.71%
377,775 $17.2 Million
Q1 2023

May 08, 2023

SELL
$37.58 - $52.57 $875,087 - $1.22 Million
-23,286 Reduced 5.6%
392,325 $15.9 Million
Q4 2022

Feb 03, 2023

SELL
$49.7 - $57.71 $1.21 Million - $1.41 Million
-24,417 Reduced 5.55%
415,611 $21.2 Million
Q3 2022

Nov 02, 2022

BUY
$53.86 - $66.8 $3.88 Million - $4.81 Million
71,975 Added 19.56%
440,028 $23.7 Million
Q2 2022

Aug 08, 2022

BUY
$63.83 - $80.0 $741,704 - $929,600
11,620 Added 3.26%
368,053 $23.6 Million
Q1 2022

May 10, 2022

SELL
$76.85 - $89.45 $19.3 Million - $22.5 Million
-251,021 Reduced 41.32%
356,433 $27.6 Million
Q4 2021

Feb 09, 2022

BUY
$74.57 - $87.19 $17.9 Million - $21 Million
240,452 Added 65.52%
607,454 $52.1 Million
Q3 2021

Nov 10, 2021

BUY
$73.77 - $83.61 $14.6 Million - $16.5 Million
197,695 Added 116.77%
367,002 $29.5 Million
Q2 2021

Aug 09, 2021

BUY
$80.5 - $88.01 $778,918 - $851,584
9,676 Added 6.06%
169,307 $13.6 Million
Q1 2021

May 07, 2021

BUY
$76.38 - $86.03 $1.14 Million - $1.29 Million
14,974 Added 10.35%
159,631 $13.5 Million
Q4 2020

Feb 11, 2021

BUY
$75.39 - $82.36 $1.27 Million - $1.39 Million
16,847 Added 13.18%
144,657 $11.6 Million
Q3 2020

Nov 12, 2020

SELL
$78.33 - $90.73 $60,000 - $69,499
-766 Reduced 0.6%
127,810 $10.3 Million
Q2 2020

Aug 07, 2020

SELL
$78.66 - $94.14 $169,119 - $202,401
-2,150 Reduced 1.64%
128,576 $11.1 Million
Q1 2020

May 05, 2020

SELL
$71.57 - $93.3 $14,457 - $18,846
-202 Reduced 0.15%
130,726 $10.6 Million
Q4 2019

Feb 10, 2020

BUY
$76.7 - $88.45 $927,686 - $1.07 Million
12,095 Added 10.18%
130,928 $10.9 Million
Q3 2019

Nov 12, 2019

SELL
$81.4 - $89.78 $16,280 - $17,956
-200 Reduced 0.17%
118,833 $10.4 Million
Q2 2019

Aug 12, 2019

SELL
$73.44 - $82.41 $14,320 - $16,069
-195 Reduced 0.16%
119,033 $9.75 Million
Q1 2019

May 14, 2019

BUY
$64.48 - $81.31 $3.33 Million - $4.2 Million
51,642 Added 76.41%
119,228 $9.69 Million
Q4 2018

Feb 11, 2019

SELL
$61.45 - $77.8 $150,183 - $190,143
-2,444 Reduced 3.49%
67,586 $4.45 Million
Q3 2018

Nov 05, 2018

SELL
$70.71 - $77.75 $44,193 - $48,593
-625 Reduced 0.88%
70,030 $5.4 Million
Q2 2018

Aug 06, 2018

SELL
$63.43 - $75.41 $6,343 - $7,541
-100 Reduced 0.14%
70,655 $5.22 Million
Q1 2018

May 09, 2018

SELL
$62.56 - $72.26 $159,840 - $184,624
-2,555 Reduced 3.49%
70,755 $4.6 Million
Q4 2017

Feb 13, 2018

SELL
$61.45 - $66.05 $82,957 - $89,167
-1,350 Reduced 1.81%
73,310 $4.74 Million
Q3 2017

Nov 08, 2017

BUY
$59.5 - $64.61 $4.44 Million - $4.82 Million
74,660
74,660 $4.69 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.5B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Cannell & Co. Portfolio

Follow Cannell & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.